Aug 6, 2026 06:55AM
Jul 27, 2026 06:32AM
Jul 24, 2026 10:18AM
Jul 24, 2026 07:51AM
Jul 24, 2026 06:53AM
Jul 23, 2026 05:42PM
Jul 23, 2026 04:25PM Summit Therapeutics: substantial doubt about our ability to continue as a going concern
Jul 23, 2026 04:06PM
Jul 23, 2026 07:10AM
Jul 22, 2026 04:30PM
Jul 22, 2026 06:30AM
Jul 16, 2026 06:48AM
Jul 15, 2026 07:37AM
Jun 22, 2026 09:26AM Summit Therapeutics plc (SMMT) PT Raised to $9.80 at Bernstein SocGen Group
Jun 12, 2026 12:37PM
Jun 3, 2026 06:51AM
Jun 1, 2026 08:23AM
Jun 1, 2026 07:55AM
Jun 1, 2026 07:41AM
Jun 1, 2026 02:53AM
May 26, 2026 09:14AM Bernstein SocGen Reiterates Underperform Rating on Summit Therapeutics plc (SMMT)
May 22, 2026 07:28AM
May 22, 2026 06:35AM
May 22, 2026 05:02AM
May 21, 2026 04:37PM
May 4, 2026 07:32AM
Apr 30, 2026 04:56PM
Apr 21, 2026 12:33PM Stifel on Summit Therapeutics plc (SMMT): 'first look, ever, at an emerging OS from an invonescimab P3 randomized against antiPD-1 (tislelizumab)'
Apr 17, 2026 09:58AM
Apr 16, 2026 03:26PM
Apr 7, 2026 04:27PM
Apr 6, 2026 07:40AM
Mar 27, 2026 08:16AM
Mar 23, 2026 04:53AM
Mar 16, 2026 12:50AM Jefferies Downgrades Summit Therapeutics plc (SMMT) to Hold
Feb 25, 2026 06:38AM
Feb 24, 2026 05:15AM
Feb 24, 2026 04:31AM
Feb 23, 2026 04:22PM
Feb 2, 2026 06:50AM
Jan 30, 2026 05:41AM
Jan 29, 2026 07:30AM FDA accepts Summit Therapeutics BLA for lung cancer drug ivonescimab
Jan 14, 2026 06:54AM
Jan 13, 2026 04:21AM
Jan 12, 2026 06:15AM
Jan 12, 2026 06:01AM
Dec 19, 2025 06:56AM
Dec 17, 2025 04:02AM
Nov 7, 2025 09:02AM Ivonescimab shows survival benefit in lung cancer study
Oct 31, 2025 07:00AM

432,977 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All